| Literature DB >> 12190303 |
Eric E Swayze1, Elizabeth A Jefferson, Kristin A Sannes-Lowery, Lawrence B Blyn, Lisa M Risen, Satoshi Arakawa, Stephen A Osgood, Steven A Hofstadler, Richard H Griffey.
Abstract
A technique for lead discovery vs RNA targets utilizing mass spectrometry (MS) screening methods is described. The structure-activity relationships (SAR) derived from assaying weak binding motifs allows the pharmacophores discovered to be elaborated via "SAR by MS" to higher affinity ligands. Application of this strategy to a subdomain of the 23S rRNA afforded a new class of compounds with functional activity.Mesh:
Substances:
Year: 2002 PMID: 12190303 DOI: 10.1021/jm0255466
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446